Surgical Wound Infection Prevention Bundle in Patients Undergoing Coronary Bypass Graft Surgery

Surgical Wound Infection Prevention Bundle in Patients Undergoing Coronary Bypass Graft Surgery Sohag Experience

Status

Completed

Phases

Unknown

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT07003750

Enrollment

200

Registered

2025-06-04

Start date

2025-07-01

Completion date

2026-06-30

Last updated

2026-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infection Due to Coronary Artery Bypass Graft (Diagnosis)

Brief summary

estimate the utilization of locally customized surgical wound infection bundle to prevent and or control of infection in patients undergoing CABG surgery in Sohag

Interventions

OTHERSurgical wound infection prevention bundle

utilization of locally customized surgical wound infection bundle to prevent and or control of infection in patients undergoing CABG surgery

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* coronary artery disease ,diebetes mellitus,hypertension,

Exclusion criteria

* patients who have cancer , immunocompromised patients, cardiac surgeries other than CABG

Design outcomes

Primary

Measure	Time frame	Description
surgical site wound infection	From enrollment to 6 months after surgery	Early complications including superficial and deep surgical site infection. Late complications including DSWI, systemic and chronic sinus

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 10, 2026